Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent
Nutriband Inc. Files Pro Forma Financials Consolidating the Recent Acquisition of Pocono Coated Products Transdermal and Topical Business and Active Intelligence
Nutriband Inc. Signs Exclusive License Agreement with RAMBAM Hospital Group for its Closed System Transfer Device
Nutriband Inc. Records Record 375% Year-Over-Year Increase in Third Quarter Revenues and Record 69% Increase for Its Nine Month Revenues
To find out more, or to enquire about our partnership options, please contact our team who can help find the right solution for your business.
